바이오테크 보도자료
-
- Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
- Merck, a leading science and technology company, today announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. (NMS) for the next-generation highly selective and brain-penetrant PARP1 (poly (ADP-ribose) poly...
- 2022년 09월 22일
-
- Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
- Nerviano Medical Sciences S.r.l. (NMS), a member of the NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, announced today the signing of a collaboration agreement with licensing opt...
- 2022년 09월 22일
-
- Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States
- Takeda (TSE:4502/NYSE:TAK) and Enel North America today announced the signing of a long-term virtual power purchase agreement (VPPA) for the electricity delivered to the power grid from a 79 megawatt (MW) portion of Enel’s Seven Cowboy wind projec...
- 2022년 09월 20일
-
- SPIE 2023 Startup Challenge Open for Applications
- Applications are now open for the 2023 SPIE Startup Challenge. The annual entrepreneurial pitch competition is held by SPIE, the international society for optics and photonics, as part of SPIE Photonics West. In 2023, Photonics West will be held 2...
- 2022년 09월 16일
-
- Philip Morris International Announces Appointment of Two Former U.S. FDA Officials, Highlighting the Company’s Continued Commitment to Smoke-Free Product Science and Regulation
- Philip Morris International Inc. (PMI) (NYSE: PM) announced today that it has appointed two former United States Food and Drug Administration (U.S. FDA) officials to key positions to accelerate its science-based transformation. Dr. Badrul Chowdhur...
- 2022년 09월 15일
-
- Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic Antibody-based Cell Therapy
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced a strategic collaboration with Guangzhou FineImmune Biotechnology Co., LTD. (“FineImmune”) to co-develop cell-based therapeutic drugs targeting intracellular tumo...
- 2022년 09월 15일
-
- Prolific Machines Raises $42M From Top Planetary Health Investors to Build the Assembly Line for Biology
- Prolific Machines, a next generation biotechnology company, is emerging from stealth today by announcing their massively oversubscribed Seed and Series A financings, led by the best VCs in the space. The Seed round was led by Arvind Gupta at Mayfi...
- 2022년 09월 15일
-
- Takeda Selects New Partners for Global Corporate Social Responsibility (CSR) Program to Strengthen Health Systems in Low- and Middle-Income Countries
- Takeda (TSE:4502/NYSE:TAK) today announced four new partnerships to its Global Corporate Social Responsibility (CSR) Program, which makes long-term commitments to strengthen healthcare for people in developing and emerging countries. Even the best...
- 2022년 09월 14일
-
- VeriSilicon Announces the One-Stop VeriHealth Chip Design Platform for Smart Healthcare Applications
- VeriSilicon (688521.SH), a leading Silicon Platform as a Service (SiPaaS®) company, today announced the launch of its customizable one-stop health chip design platform-VeriHealth™. Based on VeriSilicon’s own low-power IP series and advanced SoC cu...
- 2022년 09월 14일
전시회
